Cosyntropin

Drug West Therapeutics Development, LLC
Total Payments
$25,355
Transactions
20
Doctors
12
Companies
2

Payment Trends by Year

Year Amount Transactions Doctors
2018 $25,355 20 12

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $25,355 20 100.0%

Top Doctors Receiving Payments for Cosyntropin

Doctor Specialty Location Total Records
, MD Pediatrics Raleigh, NC $7,824 4
, MD PHD Neurology with Special Qualifications in Child Neurology Boston, MA $2,100 2
, M.D Neurodevelopmental Disabilities Los Angeles, CA $2,100 2
, MD Neurology with Special Qualifications in Child Neurology Memphis, TN $2,100 2
, M.D Neurodevelopmental Disabilities Los Angeles, CA $2,100 2
, MD Neurology Sacramento, CA $2,100 2
, M.D Neurology Sacramento, CA $1,781 1
, MD, PHD, FAAN Clinical Neurophysiology Boise, ID $1,050 1
, M.D, PH.D Sleep Medicine New York, NY $1,050 1
, MD Epilepsy New Orleans, LA $1,050 1
, DO Neurology with Special Qualifications in Child Neurology Richmond, VA $1,050 1
, MD Neurology Chicago, IL $1,050 1

About Cosyntropin

Cosyntropin is a drug associated with $25,355 in payments to 12 healthcare providers, recorded across 20 transactions in the CMS Open Payments database. The primary manufacturer is West Therapeutics Development, LLC.

Payment data is available from 2018 to 2018. In 2018, $25,355 was paid across 20 transactions to 12 doctors.

The most common payment nature for Cosyntropin is "Consulting Fee" ($25,355, 100.0% of total).